IS7351A - Kristölluð karvedílól á föstu formi og aðferðir til að framleiða þau - Google Patents

Kristölluð karvedílól á föstu formi og aðferðir til að framleiða þau

Info

Publication number
IS7351A
IS7351A IS7351A IS7351A IS7351A IS 7351 A IS7351 A IS 7351A IS 7351 A IS7351 A IS 7351A IS 7351 A IS7351 A IS 7351A IS 7351 A IS7351 A IS 7351A
Authority
IS
Iceland
Prior art keywords
producing
methods
solid crystalline
crystalline carvedilol
carvedilol
Prior art date
Application number
IS7351A
Other languages
English (en)
Icelandic (is)
Inventor
Kor Ilan
Wizel Shlomit
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23371828&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7351(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of IS7351A publication Critical patent/IS7351A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
IS7351A 2002-01-15 2004-07-13 Kristölluð karvedílól á föstu formi og aðferðir til að framleiða þau IS7351A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34931002P 2002-01-15 2002-01-15
PCT/US2003/001137 WO2003059807A2 (en) 2002-01-15 2003-01-15 Crystalline solids of carvedilol and processes for their preparation

Publications (1)

Publication Number Publication Date
IS7351A true IS7351A (is) 2004-07-13

Family

ID=23371828

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7351A IS7351A (is) 2002-01-15 2004-07-13 Kristölluð karvedílól á föstu formi og aðferðir til að framleiða þau

Country Status (14)

Country Link
US (3) US6710184B2 (US20030166702A1-20030904-C00001.png)
EP (1) EP1474133A4 (US20030166702A1-20030904-C00001.png)
JP (1) JP2005515226A (US20030166702A1-20030904-C00001.png)
KR (1) KR20040077872A (US20030166702A1-20030904-C00001.png)
CN (1) CN1298322C (US20030166702A1-20030904-C00001.png)
AU (1) AU2003205146A1 (US20030166702A1-20030904-C00001.png)
CA (1) CA2472377A1 (US20030166702A1-20030904-C00001.png)
HR (1) HRP20040673A2 (US20030166702A1-20030904-C00001.png)
IS (1) IS7351A (US20030166702A1-20030904-C00001.png)
MX (1) MXPA04006909A (US20030166702A1-20030904-C00001.png)
NO (1) NO20043383L (US20030166702A1-20030904-C00001.png)
PL (1) PL371409A1 (US20030166702A1-20030904-C00001.png)
WO (1) WO2003059807A2 (US20030166702A1-20030904-C00001.png)
ZA (1) ZA200405443B (US20030166702A1-20030904-C00001.png)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6389455B1 (en) * 1998-09-22 2002-05-14 Richard C. Fuisz Method and apparatus for bouncing electronic messages
US20010036959A1 (en) * 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions
WO2002000216A1 (en) 2000-06-28 2002-01-03 Teva Pharmaceutical Industries Ltd. Carvedilol
US7122376B2 (en) * 2001-11-01 2006-10-17 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
US7049146B2 (en) 2000-11-14 2006-05-23 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US6710184B2 (en) 2002-01-15 2004-03-23 Teva Pharmaceutical Industries Ltd. Crystalline solids of carvedilol and processes for their preparation
EP1499310A4 (en) * 2002-04-30 2005-12-07 Sb Pharmco Inc MONOCITRATE MONOHYDRATE OF CARVEDILOL
JP2005533823A (ja) * 2002-06-27 2005-11-10 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド リン酸カルベジロール塩および／またはその溶媒和物、対応する組成物、および／または治療方法
WO2004002472A1 (en) * 2002-06-27 2004-01-08 Sb Pharmco Puerto Rico Inc. Carvedilol hydrobromide
US20040152756A1 (en) * 2002-07-15 2004-08-05 Wei Chen Carvedilol polymorph
WO2004094378A1 (en) * 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
US20050042182A1 (en) * 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
US20050037040A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of urea and ammonium lactate
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
US20050069499A1 (en) * 2003-09-25 2005-03-31 Moshe Arkin Foamable compositions, processes of preparing same and uses thereof
EP1686986A4 (en) * 2003-11-25 2009-05-27 Sb Pharmco Inc CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT
EP1686967A4 (en) * 2003-11-25 2012-08-08 Smithkline Beecham Cork Ltd CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
US20060057075A1 (en) * 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
WO2006135757A1 (en) * 2005-06-09 2006-12-21 Teva Pharmaceutical Industries Ltd. Crystalline forms of carvedilol and processes for their preparation
WO2007043938A1 (en) * 2005-10-07 2007-04-19 Astrazeneca Ab NOVEL CRYSTALLINE FORM OF 3,5-DIBROMO-N- [ (2S) -2- (-4- FLUOROPHENYL) -4- (3-MORPHOLIN-4-YLAZTIDIN-l-YL) BUTYL] -N METHYLBENZAMIDE, MODIFICATION B
WO2007077111A1 (en) * 2005-12-30 2007-07-12 F. Hoffmann-La Roche Ag Compounds and methods for carbazole synthesis
US8022094B2 (en) 2006-06-28 2011-09-20 Teva Pharmaceutical Industries Ltd. Carvedilol phosphate
GB2442238B (en) * 2006-09-29 2008-10-01 Rolls Royce Plc Sheet metal blank
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
CA2705884A1 (en) * 2007-11-14 2009-05-22 Manuel Gidekel New extracts of deschampsia antarctica desv. with antineoplastic activity
WO2015031914A1 (en) * 2013-08-30 2015-03-05 Uti Limited Partnership Store overload-induced calcium release inhibitors and methods for producing and using the same
PE20160945A1 (es) 2013-11-15 2016-09-26 Akebia Therapeutics Inc Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acetico, composiciones, y usos de las mismas

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3319027A1 (de) 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten
FR2725623A1 (fr) 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
US5760069A (en) 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure
US6730326B2 (en) 1997-07-22 2004-05-04 Roche Diagnostics Gmbh Thermodynamically stable modification of 1-(4-carbazolyl-oxy-3[2-(2-methoxyphenoxy)-ethylamino]-2-propanol process for its preparation and pharmaceutical compositions containing it
EP0893440A1 (en) * 1997-07-22 1999-01-27 Roche Diagnostics GmbH Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
HU227441B1 (en) * 1997-11-24 2011-06-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing carvedilol, enantiomers and salts thereof
DE19954569A1 (de) 1999-11-12 2001-05-17 Schwabe Willmar Gmbh & Co Pharmakologisch aktive Tetrahydrothiopyran-4-ol-Derivate, Verfahren zu ihrer Herstellung und Verwendung
WO2002000216A1 (en) * 2000-06-28 2002-01-03 Teva Pharmaceutical Industries Ltd. Carvedilol
JP4056883B2 (ja) 2001-01-25 2008-03-05 エフ．ホフマン−ラ ロシュ アーゲー ヘテロ環式インデン類似体の調製方法
DE60212130D1 (en) * 2001-07-13 2006-07-20 Smithkline Beecham Corp Carvedilolpolymorph
JP2005507899A (ja) 2001-09-28 2005-03-24 エフ．ホフマン−ラ　ロシュ　アーゲー カルベジロールの疑似多形形態
US6710184B2 (en) 2002-01-15 2004-03-23 Teva Pharmaceutical Industries Ltd. Crystalline solids of carvedilol and processes for their preparation
JP2005533823A (ja) 2002-06-27 2005-11-10 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド リン酸カルベジロール塩および／またはその溶媒和物、対応する組成物、および／または治療方法
US20040152756A1 (en) * 2002-07-15 2004-08-05 Wei Chen Carvedilol polymorph
SK285547B6 (sk) 2002-11-08 2007-03-01 Zentiva, A. S. Spôsob prípravy Carvedilolu
WO2004094378A1 (en) 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
WO2004113296A1 (en) 2003-06-20 2004-12-29 Sun Pharmaceutical Industries Limited A process for preparation of 1-[9h-carbazol-4-yloxy]- 3-[{2-(2-(-(methoxy)phenoxy)-ethyl}-amino]-propan-2-ol
SI21616A (sl) 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
EP1686986A4 (en) 2003-11-25 2009-05-27 Sb Pharmco Inc CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT
CA2560353A1 (en) 2004-02-23 2005-09-01 Cadila Healthcare Limited Process for manufacture of racemic carvedilol
US20070191456A1 (en) 2004-04-22 2007-08-16 Tarur Venkatasubramanian R Novel process for the preparation of 1-(9h-carbazol-4-yloxy)-3-[[2-(-methoxyphenoxy)-ethyl] amino]-propan-2-ol
GB0411273D0 (en) 2004-05-20 2004-06-23 Cipla Ltd Process and product
WO2006061364A1 (en) 2004-12-09 2006-06-15 Zach System S.P.A. Process for the preparation of carvedilol and its enantiomers
US20070027202A1 (en) 2005-06-07 2007-02-01 Ashok Kumar Process for the preparation of carvedilol and its salts
WO2007057316A2 (en) 2005-11-16 2007-05-24 F. Hoffmann-La Roche Ag Novel process for the preparation of thoc
WO2007077111A1 (en) 2005-12-30 2007-07-12 F. Hoffmann-La Roche Ag Compounds and methods for carbazole synthesis
KR100746455B1 (ko) 2006-02-23 2007-08-03 안국약품 주식회사 고광학순도의 키랄 카베딜롤의 제조방법

Also Published As

Publication number Publication date
CN1615133A (zh) 2005-05-11
US7598396B2 (en) 2009-10-06
JP2005515226A (ja) 2005-05-26
US20090163721A1 (en) 2009-06-25
US20030166702A1 (en) 2003-09-04
EP1474133A2 (en) 2004-11-10
US20040171665A1 (en) 2004-09-02
CN1298322C (zh) 2007-02-07
US7514467B2 (en) 2009-04-07
EP1474133A4 (en) 2006-02-01
HRP20040673A2 (en) 2005-06-30
AU2003205146A1 (en) 2003-07-30
MXPA04006909A (es) 2005-04-19
WO2003059807A2 (en) 2003-07-24
CA2472377A1 (en) 2003-07-24
PL371409A1 (en) 2005-06-13
WO2003059807A3 (en) 2003-12-04
ZA200405443B (en) 2005-07-08
NO20043383L (no) 2004-08-13
US6710184B2 (en) 2004-03-23
KR20040077872A (ko) 2004-09-07

Similar Documents

Publication Publication Date Title
IS7351A (is) Kristölluð karvedílól á föstu formi og aðferðir til að framleiða þau
NO20031776D0 (no) Null-boringskomplettering og produksjonssystem
IS7045A (is) Tæki og aðferð til að framleiða háþrýstivetni
GB2413139B (en) Alternative packer setting method
NO20090890L (no) Ekspanderbart nedihullsverktøy og fremgangsmåte for ekspandering av nedihullsverktøyet
IS7768A (is) Aðferðir til framleiðslu, einangrunar og hreinsunar epóþílóns B, og röntgengeisla kristallabyggingar epóþílóns B
NO20051397D0 (no) Enkeltfase samlingsapparat og fremgangsmate
DK2336147T3 (da) Beta-immunogen-peptid-bærerkonjugater og fremgangsmåder til fremstilling deraf
IS2775B (is) Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra
NO20055633D0 (no) Oralt snusprodukt og fremgangsmate for a fremstille snusproduktet
NO20055759D0 (no) Fremgangsmate og system for nedihullsklokke
IS7335A (is) Tæki og aðferð til að búa til kristallaðar agnir
NO20034283D0 (no) Fremgangsmåte og anordning for fremstilling av syntesegass
NO20034282L (no) Fremgangsmate og anordning for fremstilling av syntesegass
IS7402A (is) Ný kristölluð form atorvastatínhálfkalsíums og aðferðir til að framleiða þau, auk nýrra aðferða tilað framleiða atorvastatínhálfkalsíum form I, VIIIog IX
EP1480260A4 (en) PROCESS FOR PRODUCING CRYSTAL
NO20052188D0 (no) System og fremgangsmate for fremstilling av polysulfid
DK1568280T3 (da) Fremgangsmåde til fremstilling af fermenteret mælk og fermenteret mælk
NO20053443L (no) Innretning og fremgangsmate for fremstilling av isolasjonselementer
GB2418692B (en) Expansion set packer
SI1519928T1 (sl) Postopek izdelave heterocikličnih fluoroalkenilsulfonov
EP1624094A4 (en) PROCESS FOR PRODUCING MONOCRYSTAL AND MONOCRYSTAL OBTAINED BY THIS PROCESS
NO20053984L (no) Fremgangsmate og innretning for maskinell gjenvinning av fiskekjott
DK1481075T3 (da) L-threoninproducerende bakterier og fremgangsmåde til fremstilling af L-threonin
NO20026234D0 (no) Bygningselement og fremgangsmåte for å fremstille slikt element